Plasmatic isoforms of cytokeratin 18 and RAGE after severe trauma: A longitudinal cohort study

Journal of Trauma and Acute Care Surgery

Volumn 77, Issue 4, 2014, Pages 577-584

  Uhle, Florian ^a   Van Den Nouland, Denise ^a   Little, Simon ^a   Menges, Thilo ^a   Weiterer, Sebastian ^a   Szalay, Gabor ^a   Franke, Jörg ^b   Schnettler, Reinhard ^a   Weigand, Markus Alexander ^a   Lichtenstern, Christoph ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Elbeklinikum   (Germany)

Author keywords

CK18; esRAGE; Severe trauma; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CYTOKERATIN 18; INTERLEUKIN 6; ISOPROTEIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ABDOMINAL INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APACHE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTURE; HUMAN; INJURY SCALE; INJURY SEVERITY; LIVER DYSFUNCTION; LONGITUDINAL STUDY; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE TRAUMA; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THORAX INJURY; TRAFFIC ACCIDENT; ADOLESCENT; BLOOD; INJURY; LIVER; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INJURY SEVERITY SCORE; KERATIN-18; LIVER; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84916630438     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000376     Document Type: Article

References (27)

1. Krug EG, Sharma GK, Lozano R. The global burden of injuries. Am J Public Health. 2000;90(4):523-526.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349(9064): 1498-1504.
3. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36(6): 691-709.
4. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol. 2007;83(3):536-545.
5. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-195.
6. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, JungerW, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104-107.
7. Kramer G, Erdal H, Mertens HJMM, NapM,Mauermann J, Steiner G, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004;64(5): 1751-1756.
8. Leers MP, KölgenW, Björklund V, Bergman T, Tribbick G, Persson B, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neoepitope exposed during early apoptosis. J Pathol. 1999;187(5):567-572.
9. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9(5):353-363.
10. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-820.
11. Barlovic DP, Soro Paavonen A, Jandeleit Dahm KAM. RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond). 2011;121(2):43-55.
12. Yan SD, Chen X, Fu J, ChenM, Zhu H, Roher A, et al. RAGE and amyloidbeta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382(6593): 685-691.
13. Bopp C, Bierhaus A, Hofer S, Bouchon A, Nawroth PP, Martin E, et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care. 2008;12(1):201.
14. Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)Ymediated signal transduction. J Biol Chem. 2010;285 (30):23137-23146.
15. Wang Y, Wang H, Piper MG, McMaken S, Mo X, Opalek J, et al. sRAGE induces human monocyte survival and differentiation. J Immunol. 2010;185(3):1822-1835.
16. Brett J, Schmidt AM, Yan SD, Zou YS,Weidman E, Pinsky D, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 1993;143(6):1699-1712.
17. Katsuoka F, Kawakami Y, Arai T, Imuta H, Fujiwara M, Kanma H, et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun. 1997;238(2):512-516.
18. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes to cells: devoted to molecular and cellular mechanisms. Genes Cells. 2004;9(2):165-174.
19. Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.
20. Cohen MJ, Carles M, Brohi K, Calfee CS, Rahn P, Call MS, et al. Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans. J Trauma. 2010;68(6):1273-1278.
21. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care. 2009;13(6):R174.
22. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008;22(10):3716-3727.
23. Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients∗. Crit Care Med. 2011;39(3):480-488.
24. Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60:1063-1074.
25. Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, et al. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care. 2009;13(3):R93.
26. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, et al. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res. 2008;147(1):79-83.
27. Benns M, Carr B, Kallan MJ, Sims CA. Benchmarking the incidence of organ failure after injury at trauma centers and nontrauma centers in the United States. J Trauma Acute Care Surg. 2013;75(3):426-431.